TiHo Bibliothek elib - Tierärztliche Hochschule Hannover
Teilen Einbetten Melden
ePaper herunterladen

TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

TiHo Bibliothek elib - Tierärztliche Hochschule Hannover TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

elib.tiho.hannover.de
von elib.tiho.hannover.de Mehr von diesem Publisher
28.02.2014 Aufrufe

LITERATURVERZEICHNIS CAEMAERT, J., VAN ROOST, D., 2007a. Deep brain stimulation in patients with refractory temporal lobe epilepsy. Epilepsia 48: 1551-1560. BOURNISSEN, F.G., MORETTI, M.E., JUURLINK, D.N., KOREN, G., WALKER, M., FINKELSTEIN, Y., 2009. Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis. Epilepsia 50: 898–903. BRANDT, C., BETHMANN, K., GASTENS, A.M., LÖSCHER, W., 2006. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis. 24: 202-211. BRIGGER, I., MORIZET, J., AUBERT, G., CHACUN, H., TERRIER-LACOMBE, M.J., COUVREUR, P., VASSAL, G., 2002. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting. J Pharmacol Exp Ther. 303: 928-936. BRINKMANN, U., EICHELBAUM, M., 2001. Polymorphisms in the ABC drug transporter gene MDR1. Pharmacogenomics J. 1: 59-64. CALABRIA, A.R., WEIDENFELLER, C., JONES, A.R., DEVRIES ,H.E., SHUSTA, E.V., 2006. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J. Neurochem. 97: 922–933. CARDOSO, F.L., BRITES, D., BRITO, M.A., 2010. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev. 64: 328-363. CARL, S.M., LINDLEY, D.J., COURAUD, P.O., WEKSLER, B.B., ROMERO, I., MOWERY, S.A., KNIPP, G.T., 2010. ABC and SLC transporter expression and pot substrate characterization across the human CMEC/D3 blood-brain barrier cell line. Mol Pharm. 7: 1057-1068. CECCHELLI, R., BEREZOWSKI, V., LUNDQUIST, S., CULOT, M., RENFTEL, M., DEHOUCK, M.P., FENART, L., 2007. Modelling of the blood–brain barrier in drug discovery and development. Nat. Rev. Drug Discov. 6: 650–661. CECCHELLI, R., DEHOUCK, B., DESCAMPS, L., FENART, L., BUÉE-SCHERRER, V., DUHEM, C., LUNDQUIST, S., RENTFEL, M., TORPIER, G., DEHOUCK, M.P., 1999. In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 36: 165-178. CERVENY, L., PAVEK, P., MALAKOVA, J., STAUD, F., FENDRICH, Z., Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents. Epilepsia 47: 461-468. CHEN, C.J., CHIN, J.E., UEDA, K., CLARK, D.P., PASTAN, I., GOTTESMAN, M.M., RONINSON, I.B., 1986. Internal duplication and homology with bacterial transport proteins in the mdr1 (Pglycoprotein) gene from multidrug-resistant human cells. Cell 47: 381–389. CHEN, J., RAYMOND, K., 2006. Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. Ann. Clin. Microbiol. Antimicrob. 5: 3. CHEN, T., 2010. Overcoming drug resistance by regulating nuclear receptors. Adv. Drug Deliv. Rev. 62: 1257-1264. CHEN, Y., FERGUSON, S.S., NEGISHI, M., GOLDSTEIN, J.A., 2004. Induction of human CYP2C9 by rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J Pharmacol Exp Ther. 308: 495-501. 182

LITERATURVERZEICHNIS CISTERNINO, S., MERCIER, C., BOURASSET, F., ROUX, F., SCHERRMANN, J.M., 2004. Expression, up-regulation, and transport activity of the multidrugresistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res. 64: 3296-3301. CLAUDE, P., 1978. Morphologic factors influencing transepithelial permeability. A model for the resistance of the zonula occludens. J Membr Biol 39: 219-232. COISNE, C., DEHOUCK, L., FAVEEUW, C., DELPLACE, Y., MILLER, F., LANDRY, C., MORISSETTE, C., FENART, L., CECCHELLI, R., TREMBLAY, P., DEHOUCK, B., 2005. Mouse syngenic in vitro blood–brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. Lab. Invest. 85: 734–746. COLABUFO, N.A.; BERARDI, F.; CANTORE, M.; CONTINO, M.; INGLESE, C.; NISO, M.; PERRONE, R., 2010. Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials. J. Med. Chem. 53: 1883-1897. COLE, S.P., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M., DEELEY, R.G., 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 2: 1650-1654. CORDON-CARDO, C., O'BRIEN, J.P., CASALS, D., RITTMAN-GRAUER, L., BIEDLER, J.L., MELAMED, M.R.,, BERTINO, J.R., 1989. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695–698. CROWE, A., TEOH, Y.K., 2006. Limited P-glycoprotein mediated efflux for anti-epileptic drugs. J. Drug. Target. 14: 291-300. CUCULLO, L., COURAUD, P.O., WEKSLER, B., ROMERO, I.A., HOSSAIN, M., RAPP, E., JANIGRO, D., 2008. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J. Cereb. Blood Flow Metab. 28: 312–328. CUCULLO, L., HOSSAIN, M., RAPP, E., MANDERS, T., MARCHI, N., JANIGRO, D., 2007. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs. Epilepsia. 48: 505-516. CUCULLO, L., MCALLISTER, M.S., KIGHT, K., KRIZANAC-BENGEZ, L., MARRONI, M., MAYBERG, M.R., STANNESS, K.A., JANIGRO, D., 2002. A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood–brain barrier. Brain Res. 951: 243–254. DANIELS, B.P., CRUZ-ORENGO, L., PASIEKA, T.J., COURAUD, P.O., ROMERO, I.A., WEKSLER, B., COOPER, J.A., DOERING, T.L., KLEIN, R.S., 2013. Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods. 212: 173-179. DALTON, W. S., GROGAN, T.M., MELTZER, P.S., SCHEPER, R.J., DURIE, B.G., TAYLOR, C.W., MILLER, T.P., SALMON, S.E., 1989. Drug-resistance in multiple myeloma and non-Hodgkin's 183

LITERATURVERZEICHNIS<br />

CAEMAERT, J., VAN ROOST, D., 2007a. Deep brain stimulation in patients with refractory<br />

temporal lobe epilepsy. Epilepsia 48: 1551-1560.<br />

BOURNISSEN, F.G., MORETTI, M.E., JUURLINK, D.N., KOREN, G., WALKER, M., FINKELSTEIN,<br />

Y., 2009. Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to<br />

anticonvulsant drugs: a meta-analysis. Epilepsia 50: 898–903.<br />

BRANDT, C., BETHMANN, K., GASTENS, A.M., LÖSCHER, W., 2006. The multidrug transporter<br />

hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe<br />

epilepsy. Neurobiol Dis. 24: 202-211.<br />

BRIGGER, I., MORIZET, J., AUBERT, G., CHACUN, H., TERRIER-LACOMBE, M.J., COUVREUR,<br />

P., VASSAL, G., 2002. Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres<br />

display a combined effect for brain tumor targeting. J Pharmacol Exp Ther. 303: 928-936.<br />

BRINKMANN, U., EICHELBAUM, M., 2001. Polymorphisms in the ABC drug transporter gene MDR1.<br />

Pharmacogenomics J. 1: 59-64.<br />

CALABRIA, A.R., WEIDENFELLER, C., JONES, A.R., DEVRIES ,H.E., SHUSTA, E.V., 2006.<br />

Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier<br />

properties in response to glucocorticoid induction. J. Neurochem. 97: 922–933.<br />

CARDOSO, F.L., BRITES, D., BRITO, M.A., 2010. Looking at the blood-brain barrier: molecular<br />

anatomy and possible investigation approaches. Brain Res Rev. 64: 328-363.<br />

CARL, S.M., LINDLEY, D.J., COURAUD, P.O., WEKSLER, B.B., ROMERO, I., MOWERY, S.A.,<br />

KNIPP, G.T., 2010. ABC and SLC transporter expression and pot substrate characterization<br />

across the human CMEC/D3 blood-brain barrier cell line. Mol Pharm. 7: 1057-1068.<br />

CECCHELLI, R., BEREZOWSKI, V., LUNDQUIST, S., CULOT, M., RENFTEL, M., DEHOUCK, M.P.,<br />

FENART, L., 2007. Modelling of the blood–brain barrier in drug discovery and development.<br />

Nat. Rev. Drug Discov. 6: 650–661.<br />

CECCHELLI, R., DEHOUCK, B., DESCAMPS, L., FENART, L., BUÉE-SCHERRER, V., DUHEM, C.,<br />

LUNDQUIST, S., RENTFEL, M., TORPIER, G., DEHOUCK, M.P., 1999. In vitro model for<br />

evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 36: 165-178.<br />

CERVENY, L., PAVEK, P., MALAKOVA, J., STAUD, F., FENDRICH, Z., Lack of interactions between<br />

breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents. Epilepsia 47:<br />

461-468.<br />

CHEN, C.J., CHIN, J.E., UEDA, K., CLARK, D.P., PASTAN, I., GOTTESMAN, M.M., RONINSON, I.B.,<br />

1986. Internal duplication and homology with bacterial transport proteins in the mdr1 (Pglycoprotein)<br />

gene from multidrug-resistant human cells. Cell 47: 381–389.<br />

CHEN, J., RAYMOND, K., 2006. Roles of rifampicin in drug-drug interactions: underlying molecular<br />

mechanisms involving the nuclear pregnane X receptor. Ann. Clin. Microbiol. Antimicrob. 5: 3.<br />

CHEN, T., 2010. Overcoming drug resistance by regulating nuclear receptors. Adv. Drug Deliv. Rev.<br />

62: 1257-1264.<br />

CHEN, Y., FERGUSON, S.S., NEGISHI, M., GOLDSTEIN, J.A., 2004. Induction of human CYP2C9 by<br />

rifampicin, hyperforin, and phenobarbital is mediated by the pregnane X receptor. J Pharmacol<br />

Exp Ther. 308: 495-501.<br />

182

logo

Produkte

Ressourcen

Unternehmen

AGB
Datenschutzerklärung
Cookie-Richtlinien
Cookie-Einstellungen
Impressum
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hurra! Ihre Datei wurde hochgeladen und ist bereit für die Veröffentlichung.

Erfolgreich gespeichert!

Leider ist etwas schief gelaufen!